Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SNY
Recent news which mentions SNY
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
26
27
Next >
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
October 01, 2022
Tickers
MRNA
PFE
SNY
Tags
SNY
PFE
MRNA
From
Motley Fool
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
September 29, 2022
Tickers
REGN
SNY
Tags
FDA
General
Briefs
From
Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
September 20, 2022
Tickers
GSK
HLN
PFE
SNY
Tags
General
Legal
Eurasia
From
Benzinga
Multiple Sclerosis Is A Crowded Space, But This Stock Is A Potential 6X Multi-bagger
September 19, 2022
Tickers
IMUX
RHHBY
SNY
Tags
Analyst Color
Market News
Analyst Ratings
From
Benzinga
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
Tickers
BMY
PFE
REGN
SNY
Tags
Recent Press Releases
REGN
SNY
From
Motley Fool
AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing
September 16, 2022
Tickers
AZN
AZNCF
SNY
Tags
Briefs
Benzinga
Biotech
From
Benzinga
ASLAN Pharma Starts Eblasakimab Program In Dupixent Treated Dermatitis Patients
September 14, 2022
Tickers
ASLN
REGN
SNY
Tags
Briefs
News
REGN
From
Benzinga
What's Moderna's Next Billion-Dollar Market? The Answer May Surprise You.
September 14, 2022
Tickers
MRNA
SNY
Tags
MRNA
Recent Press Releases
Market News
From
Motley Fool
Regeneron-Sanofi Eczema Drug Shows Improvements In Itchy Inflammatory Skin Disease
September 08, 2022
Tickers
REGN
SNY
Tags
Market News
Health Care
Trading Ideas
From
Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
Tickers
AZN
BNTX
GSK
MRNA
Tags
SNY
News
GSK
From
Benzinga
Sanofi-Regeneron's Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids
September 06, 2022
Tickers
REGN
SNY
Tags
Benzinga
Health Care
Biotech
From
Benzinga
Top Financial Stories Thursday, September 1: Netflix Weighs Charging High Sum For Ads, Self Harm posts Grow On Twitter, California Fast-Food Bill Faces Industry Backlash...
September 01, 2022
Tickers
AMD
AMZN
BA
BABA
Tags
Media
General
XOM
From
Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
September 01, 2022
Tickers
SNY
Tags
SNY
News
Briefs
From
Benzinga
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
Tickers
ACAD
AMGN
AMLX
AXSM
Tags
ACAD
XBI
IBB
From
Benzinga
With Approval For Dengue Vaccine, Takeda May Find It Challenging To Compete Bigger Rivals: Report
August 30, 2022
Tickers
GSK
MRK
SNY
TAK
Tags
Briefs
Biotech
Benzinga
From
Benzinga
Sanofi's Hemophilia Candidate Goes Under Priority FDA Review
August 30, 2022
Tickers
BIOVF
SNY
Tags
Health Care
Benzinga
Biotech
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
August 25, 2022
Tickers
AGFY
AKLI
ANF
APGN
Tags
FOSL
52 Week Lows
PHVS
From
Benzinga
TG Therapeutics Touts Encouraging Data From Multiple Sclerosis Candidate
August 25, 2022
Tickers
SNY
TGTX
Tags
General
Small Cap
TGTX
From
Benzinga
Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources
August 24, 2022
Tickers
DRIO
PEAR
SNY
TALK
Tags
Dario
Market News
Health Care
From
Benzinga
The Rise and Fall of Novavax
August 21, 2022
Tickers
BNTX
GSK
MRK
NVAX
Tags
GSK
Recent Press Releases
SNY
From
Motley Fool
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
Tickers
AGFY
AMAM
API
ATTO
Tags
TUYA
Intraday Update
PHG
From
Benzinga
Sanofi's Breast Cancer Drug Fallout 'Creates Buying Opportunity' For This Stock
August 18, 2022
Tickers
ARVN
SNY
Tags
Price Target
Briefs
Biotech
From
Benzinga
Millions Suffering From Diabetes May Soon See Relief From Some Of The Pain And Expenses Associated
August 18, 2022
Tickers
CI
KNWN
LLY
MOVE
Tags
Partner Content
General
MOVE
From
Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
August 18, 2022
Tickers
A
AACG
ABBV
AKU
Tags
NVFY
FEDU
Small Cap
From
Benzinga
Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial
August 17, 2022
Tickers
PFE
SNY
Tags
Analyst Ratings
Market News
Analyst Color
From
Benzinga
Sanofi, Children's Place And Some Other Big Stocks Moving Lower On Wednesday
August 17, 2022
Tickers
ARVN
BPMC
CVNA
DNUT
Tags
Benzinga
UPST
ARVN
From
Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
August 17, 2022
Tickers
A
AACG
ABBV
AKU
Tags
ZIP
Consumer Discretionary
QLI
From
Benzinga
Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation Highest In 40 Years, Sole Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand And
August 17, 2022
Tickers
AAPL
AMZN
BA
BLK
Tags
Top Stories
GOOG
News
From
Benzinga
Zantac lawsuit drop ‘not as significant as it appears’ for GSK stock, analysts say
August 17, 2022
Tickers
GSK
HLN
PFE
SNY
Tags
HLN
SNY
PFE
From
MarketWatch
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
August 17, 2022
Tickers
PFE
SNY
Tags
Market News
why it's moving
Health Care
From
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.